vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Iridium Communications Inc. (IRDM). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $219.1M, roughly 1.2× Iridium Communications Inc.). BALCHEM CORP runs the higher net margin — 14.9% vs 9.9%, a 5.0% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (9.8% vs 1.9%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (4.9% CAGR vs 4.4%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Iridium Communications Inc. is a publicly traded American company headquartered in McLean, Virginia, United States. Iridium operates the Iridium satellite constellation, a system of 80 satellites: 66 are active satellites and the remaining fourteen function as in-orbit spares. Iridium Satellites are used for worldwide voice and data communication from handheld satellite phones, satellite messenger communication devices and integrated transceivers, as well as for two-way satellite messaging se...
BCPC vs IRDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $219.1M |
| Net Profit | $39.2M | $21.6M |
| Gross Margin | 35.6% | — |
| Operating Margin | 19.8% | 23.2% |
| Net Margin | 14.9% | 9.9% |
| Revenue YoY | 9.8% | 1.9% |
| Net Profit YoY | 16.8% | — |
| EPS (diluted) | $1.21 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $219.1M | ||
| Q4 25 | $263.6M | $212.9M | ||
| Q3 25 | $267.6M | $226.9M | ||
| Q2 25 | $255.5M | $216.9M | ||
| Q1 25 | $250.5M | $214.9M | ||
| Q4 24 | $240.0M | $213.0M | ||
| Q3 24 | $239.9M | $212.8M | ||
| Q2 24 | $234.1M | $201.1M |
| Q1 26 | — | $21.6M | ||
| Q4 25 | $39.2M | $24.9M | ||
| Q3 25 | $40.3M | $37.1M | ||
| Q2 25 | $38.3M | $22.0M | ||
| Q1 25 | $37.1M | $30.4M | ||
| Q4 24 | $33.6M | $36.3M | ||
| Q3 24 | $33.8M | $24.4M | ||
| Q2 24 | $32.1M | $32.3M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
| Q1 26 | — | 23.2% | ||
| Q4 25 | 19.8% | 25.9% | ||
| Q3 25 | 20.4% | 30.9% | ||
| Q2 25 | 20.1% | 23.2% | ||
| Q1 25 | 20.4% | 28.1% | ||
| Q4 24 | 19.8% | 24.5% | ||
| Q3 24 | 20.0% | 25.8% | ||
| Q2 24 | 19.6% | 21.7% |
| Q1 26 | — | 9.9% | ||
| Q4 25 | 14.9% | 11.7% | ||
| Q3 25 | 15.1% | 16.4% | ||
| Q2 25 | 15.0% | 10.1% | ||
| Q1 25 | 14.8% | 14.2% | ||
| Q4 24 | 14.0% | 17.1% | ||
| Q3 24 | 14.1% | 11.5% | ||
| Q2 24 | 13.7% | 16.1% |
| Q1 26 | — | — | ||
| Q4 25 | $1.21 | $0.24 | ||
| Q3 25 | $1.24 | $0.35 | ||
| Q2 25 | $1.17 | $0.20 | ||
| Q1 25 | $1.13 | $0.27 | ||
| Q4 24 | $1.03 | $0.30 | ||
| Q3 24 | $1.03 | $0.21 | ||
| Q2 24 | $0.98 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | — |
| Total Assets | $1.7B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $96.5M | ||
| Q3 25 | $65.1M | $88.5M | ||
| Q2 25 | $65.4M | $79.3M | ||
| Q1 25 | $49.9M | $50.9M | ||
| Q4 24 | $49.5M | $93.5M | ||
| Q3 24 | $73.7M | $159.6M | ||
| Q2 24 | $63.7M | $63.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $462.6M | ||
| Q3 25 | $1.3B | $450.5M | ||
| Q2 25 | $1.3B | $473.6M | ||
| Q1 25 | $1.2B | $518.4M | ||
| Q4 24 | $1.1B | $576.6M | ||
| Q3 24 | $1.2B | $663.8M | ||
| Q2 24 | $1.1B | $786.7M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.7B | $2.6B | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.6B | $2.6B | ||
| Q4 24 | $1.6B | $2.7B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.6B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.80× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 13.7% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $67.3M | $108.6M | ||
| Q3 25 | $65.6M | $100.8M | ||
| Q2 25 | $47.3M | $129.6M | ||
| Q1 25 | $36.5M | $61.1M | ||
| Q4 24 | $52.3M | $104.8M | ||
| Q3 24 | $51.3M | $118.6M | ||
| Q2 24 | $45.0M | $81.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $75.1M | ||
| Q3 25 | — | $79.2M | ||
| Q2 25 | — | $108.9M | ||
| Q1 25 | — | $36.5M | ||
| Q4 24 | — | $80.5M | ||
| Q3 24 | — | $100.0M | ||
| Q2 24 | — | $68.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 35.3% | ||
| Q3 25 | — | 34.9% | ||
| Q2 25 | — | 50.2% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 37.8% | ||
| Q3 24 | — | 47.0% | ||
| Q2 24 | — | 34.2% |
| Q1 26 | — | 13.7% | ||
| Q4 25 | — | 15.7% | ||
| Q3 25 | — | 9.5% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 6.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.72× | 4.37× | ||
| Q3 25 | 1.63× | 2.71× | ||
| Q2 25 | 1.23× | 5.90× | ||
| Q1 25 | 0.98× | 2.01× | ||
| Q4 24 | 1.56× | 2.88× | ||
| Q3 24 | 1.52× | 4.85× | ||
| Q2 24 | 1.40× | 2.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
IRDM
| Voice and data | $57.4M | 26% |
| IoT data (2) | $46.0M | 21% |
| Government | $39.5M | 18% |
| Government service revenue (5) | $27.6M | 13% |
| Subscriber equipment | $20.2M | 9% |
| Hosted payload and other data service (4) | $14.8M | 7% |
| Broadband (3) | $12.2M | 6% |
| Commercial | $1.3M | 1% |
